Show simple item record

Commentary: Blockade of activin type II receptors with a dual anti-actRIIA/IIB antibody is critical to promote maximal skeletal muscle hypertrophy

Authordc.contributor.authorDurán, Javier
Authordc.contributor.authorEstrada Hormazábal, Manuel
Admission datedc.date.accessioned2018-08-13T18:58:18Z
Available datedc.date.available2018-08-13T18:58:18Z
Publication datedc.date.issued2018
Cita de ítemdc.identifier.citationFrontiers in Pharmacology April 2018 | Volume 9 | Article 381es_ES
Identifierdc.identifier.other10.3389/fphar.2018.00381
Identifierdc.identifier.urihttps://repositorio.uchile.cl/handle/2250/150942
Patrocinadordc.description.sponsorshipFondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) 1151118es_ES
Lenguagedc.language.isoenes_ES
Publisherdc.publisherFrontiers Mediaes_ES
Type of licensedc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chile*
Link to Licensedc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/*
Sourcedc.sourceFrontiers in Pharmacologyes_ES
Keywordsdc.subjectBimagrumabes_ES
Keywordsdc.subjectActRIIA/B receptorses_ES
Keywordsdc.subjectSkeletal musclees_ES
Keywordsdc.subjectAnabolic steroidses_ES
Keywordsdc.subjectMyostatin/activines_ES
Títulodc.titleCommentary: Blockade of activin type II receptors with a dual anti-actRIIA/IIB antibody is critical to promote maximal skeletal muscle hypertrophyes_ES
Document typedc.typeArtículo de revista
dcterms.accessRightsdcterms.accessRightsAcceso abierto
Catalogueruchile.catalogadorrgfes_ES
Indexationuchile.indexArtículo de publicación ISIes_ES


Files in this item

Icon
Name:
Commentary-Blockade-of-activin ...
Size:
198.8Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs 3.0 Chile
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 Chile